Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
Getting a prescription for Ozempic or Wegovy is more accessible than ever in 2026 — but navigating the process can be confusing. This step-by-step guide explains exactly who qualifies, how to get prescribed, and what telehealth vs in-person options look like.
Who Qualifies for Ozempic or Wegovy?
| Medication | FDA Indication | BMI Requirement | Additional Criteria |
|---|---|---|---|
| Ozempic (semaglutide 0.5–2mg) | Type 2 diabetes management | No BMI requirement | Must have T2D diagnosis |
| Wegovy (semaglutide 2.4mg) | Chronic weight management | BMI ≥ 30, OR BMI ≥ 27 with weight-related condition | Weight-related conditions: T2D, hypertension, sleep apnea, high cholesterol, cardiovascular disease |
A BMI of 27+ with a qualifying comorbidity covers a very large percentage of American adults. If you have high blood pressure, pre-diabetes, sleep apnea, or elevated cholesterol alongside excess weight, you likely meet the clinical criteria for Wegovy.
Option 1: Your Primary Care Doctor
Your primary care physician (PCP) can prescribe both Ozempic and Wegovy. This is often the most straightforward path if you have an established relationship with a doctor. Come prepared with your current weight, height (for BMI), any diagnosed conditions (hypertension, T2D, etc.), and a clear statement of your goals. Many PCPs are now comfortable prescribing GLP-1s given how mainstream they’ve become, though some may refer you to an endocrinologist or obesity medicine specialist for complex cases.
Option 2: Telehealth GLP-1 Providers
Telehealth has made GLP-1 prescriptions dramatically more accessible. Several specialized platforms can evaluate you and prescribe Ozempic or Wegovy — often within days — without requiring an in-person visit. The evaluation typically involves a medical questionnaire, vital signs (weight, blood pressure if available), and a video or async consultation with a licensed clinician.
Leading telehealth GLP-1 providers as of 2026 include Ro Body, Hims & Hers, Found, Mochi Health, and several others. These platforms vary in cost, medications offered (some use compounded semaglutide; others prescribe brand-name Wegovy/Ozempic), and what’s included in their monthly membership.
Option 3: Endocrinologist or Obesity Medicine Specialist
For complex cases — significant comorbidities, prior medication failures, or insurance appeals — a specialist is valuable. Obesity medicine-certified physicians have specific training in pharmacological weight management and are often the most effective advocates for insurance coverage. The American Board of Obesity Medicine (ABOM) has a searchable directory at abom.org.
What to Expect at Your First Appointment
Whether in-person or telehealth, a GLP-1 consultation typically covers:
- Medical history (current conditions, medications, allergies)
- Contraindications screening (history of MTC thyroid cancer, MEN2 syndrome, pancreatitis)
- Weight and BMI assessment
- Lab work review (A1C, kidney function, thyroid, lipids) — sometimes ordered as part of the visit
- Discussion of medication options (Ozempic vs Wegovy vs compounded)
- Insurance/cost discussion and prior authorization strategy
Contraindications: Who Cannot Take Semaglutide
| Contraindication | Reason |
|---|---|
| Personal or family history of medullary thyroid carcinoma (MTC) | Black box warning; theoretical thyroid tumor risk |
| Multiple Endocrine Neoplasia syndrome type 2 (MEN2) | Associated with MTC risk |
| Known hypersensitivity to semaglutide | Rare but absolute contraindication |
| Pregnancy (or planning pregnancy within 2 months) | Potential fetal harm; stop 2 months before conception |
| Severe gastroparesis | GLP-1s slow gastric emptying and can worsen condition |
Navigating Insurance for GLP-1 Prescriptions
Insurance coverage remains the biggest hurdle. Ozempic for diabetes is generally well-covered. Wegovy for obesity requires more work — often a prior authorization (PA) with documentation of BMI, qualifying conditions, and prior weight loss attempts. Key tips:
- Ask your prescriber to document all qualifying comorbidities in their note
- Request that prior authorization is submitted promptly after your visit
- If denied, appeal with a Letter of Medical Necessity from your doctor
- Check Novo Nordisk’s savings program — commercially insured patients may pay as little as $0/month if eligible
- Ask about Ozempic as an alternative if your plan covers it more readily (often true for T2D diagnoses)
Compounded Semaglutide: What to Know
During brand-name shortages, FDA-registered compounding pharmacies produced semaglutide at lower cost. As of 2025–2026, the FDA has periodically updated its shortage status, affecting the legal availability of compounded semaglutide. Compounded versions are significantly cheaper (often $200–$400/month) but lack the same FDA oversight as branded products. If considering compounded semaglutide, ensure it’s from an FDA-registered 503B outsourcing facility and prescribed by a licensed clinician.
Frequently Asked Questions
Can I get Ozempic prescribed online?
Yes. Multiple telehealth platforms offer GLP-1 prescriptions after an online medical evaluation. These include Ro Body, Hims & Hers, Mochi Health, Found, and others. The process typically takes 1–5 days from initial sign-up to prescription.
Do I need to be diabetic to get a semaglutide prescription?
Not for Wegovy (semaglutide 2.4mg), which is approved for obesity (BMI ≥ 30 or BMI ≥ 27 with a weight-related condition). Ozempic (lower doses) is specifically for type 2 diabetes, though it’s sometimes prescribed off-label for weight loss in non-diabetic patients.
How quickly can I get a GLP-1 prescription?
Through telehealth platforms, often within 24–72 hours of your consultation. In-person with a PCP, within the same visit if your doctor is comfortable prescribing. Getting insurance approval (prior authorization) typically takes 1–4 weeks additional.
What BMI do you need for Wegovy?
BMI ≥ 30 (obesity), or BMI ≥ 27 with at least one weight-related condition such as hypertension, type 2 diabetes, sleep apnea, cardiovascular disease, or high cholesterol. Most adults with significant excess weight will qualify under one of these criteria.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.
📋 Compare Top GLP-1 Providers — Find Your Best Option
